RNAi agents for inhibiting expression of activin receptor-like kinase 7 (ALK7), compositions thereof, and methods of use
AssigneeArrowhead Pharmaceuticals, Inc.
InventorsMichelle Ngai, Mark Majewski, Zhi-Ming Ding, Agnieszka Glebocka, Tao Pei, James C. Hamilton, Grigoriy Shekhtman
Life of this patent
Estimating the term…